These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23764479)

  • 41. Genomics, personalized medicine and cancer practice.
    Dancey J
    Clin Biochem; 2012 Apr; 45(6):379-81. PubMed ID: 22424082
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of tumor sequencing on the use of anticancer drugs.
    Thomas F; Desmedt C; Aftimos P; Awada A
    Curr Opin Oncol; 2014 May; 26(3):347-56. PubMed ID: 24709974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and validation of therapeutically relevant multi-gene biomarker classifiers.
    Simon R
    J Natl Cancer Inst; 2005 Jun; 97(12):866-7. PubMed ID: 15956642
    [No Abstract]   [Full Text] [Related]  

  • 44. DNA microarrays and data analysis: an overview.
    Eschrich S; Yeatman TJ
    Surgery; 2004 Sep; 136(3):500-3. PubMed ID: 15349092
    [No Abstract]   [Full Text] [Related]  

  • 45. Risk loci, biological candidates and biomarkers.
    Nat Genet; 2008 Mar; 40(3):257. PubMed ID: 18305468
    [No Abstract]   [Full Text] [Related]  

  • 46. Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling.
    Simon R
    J Natl Cancer Inst; 2006 Sep; 98(17):1169-71. PubMed ID: 16954463
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular forecasting of breast cancer: time to move forward with clinical testing.
    Loi S; Sotiriou C; Buyse M; Rutgers E; Van't Veer L; Piccart M; Cardoso F
    J Clin Oncol; 2006 Feb; 24(4):721-2; author reply 722-3. PubMed ID: 16446348
    [No Abstract]   [Full Text] [Related]  

  • 48. Screening in GI Cancers: The Role of Genetics.
    Stoffel EM
    J Clin Oncol; 2015 Jun; 33(16):1721-8. PubMed ID: 25918283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 50. The value of new high-throughput technologies for diagnosis and prognosis in solid tumors.
    Pinto R; De Summa S; Petriella D; Tudoran O; Danza K; Tommasi S
    Cancer Biomark; 2014; 14(2-3):103-17. PubMed ID: 24878811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Categorization of cancer through genomic complexity could guide research and management strategies.
    Horlings HM; Flanagan AM; Huntsman DG
    J Pathol; 2015 Aug; 236(4):397-402. PubMed ID: 25864408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microarray analysis and tumor classification.
    Quackenbush J
    N Engl J Med; 2006 Jun; 354(23):2463-72. PubMed ID: 16760446
    [No Abstract]   [Full Text] [Related]  

  • 53. Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.
    Roberts NJ; Klein AP
    Cancer Lett; 2013 Nov; 340(2):227-33. PubMed ID: 23196058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays.
    Thomas RS; Pluta L; Yang L; Halsey TA
    Toxicol Sci; 2007 May; 97(1):55-64. PubMed ID: 17311802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Next-generation sequencing for lung cancer.
    Wu K; Huang RS; House L; Cho WC
    Future Oncol; 2013 Sep; 9(9):1323-36. PubMed ID: 23980680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Gene expression profiles in the diagnosis and prognosis of cancer].
    Kopper L; Tímár J
    Magy Onkol; 2002; 46(1):3-9. PubMed ID: 12050676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-throughput sequencing set to enter patient care.
    Hede K
    J Natl Cancer Inst; 2012 Nov; 104(21):1620-1. PubMed ID: 23104214
    [No Abstract]   [Full Text] [Related]  

  • 58. Genes versus cancer.
    Lewis R
    Nature; 2007 Apr; 446(7137):826-7. PubMed ID: 17460827
    [No Abstract]   [Full Text] [Related]  

  • 59. Accurate molecular classification of kidney cancer subtypes using microRNA signature.
    Youssef YM; White NM; Grigull J; Krizova A; Samy C; Mejia-Guerrero S; Evans A; Yousef GM
    Eur Urol; 2011 May; 59(5):721-30. PubMed ID: 21272993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer genomics: the chips are on the table.
    Holland K; Sullivan M
    N Z Med J; 2002 Oct; 115(1163):U204. PubMed ID: 12552310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.